NASDAQ:RMTI Rockwell Medical (RMTI) Stock Price, News & Analysis $1.78 +0.19 (+11.95%) As of 02:29 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Rockwell Medical Stock (NASDAQ:RMTI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Rockwell Medical alerts:Sign Up Key Stats Today's Range$1.60▼$1.8550-Day Range$0.80▼$1.8352-Week Range$0.78▼$5.15Volume3.22 million shsAverage Volume563,676 shsMarket Capitalization$61.29 millionP/E RatioN/ADividend YieldN/APrice Target$4.00Consensus RatingBuy Company Overview Rockwell Medical, Inc. is a Delaware‐domiciled biopharmaceutical company focused on the development and commercialization of therapies for patients with chronic kidney disease (CKD). The company’s mission centers on addressing common complications in CKD—namely iron deficiency and secondary hyperparathyroidism—through innovative treatment approaches designed for dialysis settings. The company’s lead product, TRIFERIC®, is an iron replacement therapy approved by the U.S. Food and Drug Administration for use in hemodialysis patients. TRIFERIC is delivered via dialysate and is intended to replace iron losses that occur during the dialysis process, helping to maintain hemoglobin levels without the need for intravenous iron supplements. In addition to TRIFERIC, Rockwell Medical offers a generic injectable formulation of calcitriol, a form of vitamin D used to manage secondary hyperparathyroidism in CKD patients. Since its founding in 1991, Rockwell Medical has conducted research, clinical development, and regulatory activities primarily in the United States. The company collaborates with specialty distributors and dialysis providers to commercialize its products and is exploring further innovations, including oral formulations of its iron therapy. Rockwell Medical’s operations are led by an experienced management team with backgrounds in nephrology, pharmaceutical development, and health-care commercialization, reflecting its commitment to improving patient outcomes in the CKD community.AI Generated. May Contain Errors. Read More Rockwell Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks78th Percentile Overall ScoreRMTI MarketRank™: Rockwell Medical scored higher than 78% of companies evaluated by MarketBeat, and ranked 235th out of 927 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingBuy Consensus RatingRockwell Medical has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Upside PotentialRockwell Medical has a consensus price target of $4.00, representing about 120.4% upside from its current price of $1.82.Amount of Analyst CoverageRockwell Medical has received no research coverage in the past 90 days.Read more about Rockwell Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Rockwell Medical are expected to decrease in the coming year, from $0.03 to ($0.03) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rockwell Medical is -30.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rockwell Medical is -30.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRockwell Medical has a P/B Ratio of 1.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Rockwell Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.61% of the float of Rockwell Medical has been sold short.Short Interest Ratio / Days to CoverRockwell Medical has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rockwell Medical has recently increased by 72.17%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldRockwell Medical does not currently pay a dividend.Dividend GrowthRockwell Medical does not have a long track record of dividend growth. Sustainability and ESG4.1 / 5Environmental Score-2.35 Percentage of Shares Shorted0.61% of the float of Rockwell Medical has been sold short.Short Interest Ratio / Days to CoverRockwell Medical has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rockwell Medical has recently increased by 72.17%, indicating that investor sentiment is decreasing significantly. News and Social Media3.3 / 5News Sentiment0.90 News SentimentRockwell Medical has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Rockwell Medical this week, compared to 2 articles on an average week.Search Interest12 people have searched for RMTI on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Rockwell Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Rockwell Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,758.00 in company stock.Percentage Held by InsidersOnly 3.60% of the stock of Rockwell Medical is held by insiders.Percentage Held by InstitutionsOnly 23.31% of the stock of Rockwell Medical is held by institutions.Read more about Rockwell Medical's insider trading history. Receive RMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RMTI Stock News HeadlinesRockwell Medical, Inc. (NASDAQ:RMTI) Q2 2025 Earnings Call TranscriptAugust 15, 2025 | msn.comRockwell Medical: Strategic Positioning and Growth Potential Justify Buy RatingAugust 15, 2025 | tipranks.comBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated billions of shares. Bill Gates sold 500,000 shares of Microsoft. Jeff Bezos filed to sell Amazon shares worth $4.8 billion. What is going on? One multi-millionaire believes they are preparing for a catastrophic event. But not a crash, bank run, or recession. It’s something we haven’t see in America for more than a century.September 9 at 2:00 AM | Banyan Hill Publishing (Ad)Rockwell Medical Reports Q2 2025 Financial ResultsAugust 15, 2025 | msn.comRockwell Medical Inc (RMTI) Q2 2025 Earnings Call Highlights: Navigating Challenges with ...August 15, 2025 | gurufocus.comQ2 2025 Rockwell Medical Inc Earnings Call TranscriptAugust 14, 2025 | gurufocus.comRockwell Medical RMTI Q2 2025 Earnings TranscriptAugust 14, 2025 | fool.comRockwell Medical, Inc. (RMTI) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comSee More Headlines RMTI Stock Analysis - Frequently Asked Questions How have RMTI shares performed this year? Rockwell Medical's stock was trading at $2.04 at the beginning of 2025. Since then, RMTI stock has decreased by 11.0% and is now trading at $1.8150. How were Rockwell Medical's earnings last quarter? Rockwell Medical, Inc. (NASDAQ:RMTI) released its earnings results on Thursday, August, 14th. The company reported ($0.05) EPS for the quarter, meeting the consensus estimate of ($0.05). The company earned $16.07 million during the quarter, compared to the consensus estimate of $16.33 million. Rockwell Medical had a negative trailing twelve-month return on equity of 6.79% and a negative net margin of 2.38%. Read the conference call transcript. When did Rockwell Medical's stock split? Rockwell Medical's stock reverse split before market open on Friday, May 13th 2022.The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split. Who are Rockwell Medical's major shareholders? Top institutional shareholders of Rockwell Medical include Armistice Capital LLC (6.29%), Globeflex Capital L P (0.91%), Marshall Wace LLP (0.51%) and Panagora Asset Management Inc. (0.14%). Insiders that own company stock include Larson Family Inve Irrevocable, Mark Strobeck, Timothy Chole, Jesse Neri and Mark H Ravich. View institutional ownership trends. How do I buy shares of Rockwell Medical? Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Rockwell Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Rockwell Medical investors own include NVIDIA (NVDA), Super Micro Computer (SMCI), Axcelis Technologies (ACLS), Opera (OPRA), ADMA Biologics (ADMA), ASML (ASML) and InterDigital (IDCC). Company Calendar Last Earnings8/14/2025Today9/09/2025Next Earnings (Estimated)11/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:RMTI CIK1041024 Webwww.rockwellmed.com Phone(248) 432-1362Fax248-960-9119Employees300Year Founded1995Price Target and Rating Average Price Target for Rockwell Medical$4.00 High Price Target$5.00 Low Price Target$3.00 Potential Upside/Downside+151.6%Consensus RatingBuy Rating Score (0-4)3.33 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.06) Trailing P/E RatioN/A Forward P/E Ratio53.00 P/E GrowthN/ANet Income-$480 thousand Net Margins-2.38% Pretax Margin-2.39% Return on Equity-6.79% Return on Assets-3.77% Debt Debt-to-Equity Ratio0.30 Current Ratio2.89 Quick Ratio2.51 Sales & Book Value Annual Sales$87.97 million Price / Sales0.62 Cash Flow$0.12 per share Price / Cash Flow12.81 Book Value$1.01 per share Price / Book1.57Miscellaneous Outstanding Shares34,430,000Free Float33,776,000Market Cap$54.74 million OptionableOptionable Beta1.83 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:RMTI) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rockwell Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rockwell Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.